These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10952707)

  • 1. Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate.
    Ebbesen F; Joergensen A; Hoseth E; Kaad PH; Moeller M; Holsteen V; Rix M
    Arch Dis Child Fetal Neonatal Ed; 2000 Sep; 83(2):F124-9. PubMed ID: 10952707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.
    Thisted E; Ebbesen F
    Arch Dis Child; 1993 Sep; 69(3 Spec No):288-91. PubMed ID: 8215567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal episodic hypoglycemia: a finding of valproic acid withdrawal.
    Çoban D; Kurtoğlu S; Akın MA; Akçakuş M; Güneş T
    J Clin Res Pediatr Endocrinol; 2010; 2(2):92-4. PubMed ID: 21274347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine.
    Deshmukh U; Adams J; Macklin EA; Dhillon R; McCarthy KD; Dworetzky B; Klein A; Holmes LB
    Neurotoxicol Teratol; 2016; 54():5-14. PubMed ID: 26791321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal intelligence in children with prenatal exposure to carbamazepine.
    Gaily E; Kantola-Sorsa E; Hiilesmaa V; Isoaho M; Matila R; Kotila M; Nylund T; Bardy A; Kaaja E; Granström ML
    Neurology; 2004 Jan; 62(1):28-32. PubMed ID: 14718692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study.
    Baker GA; Bromley RL; Briggs M; Cheyne CP; Cohen MJ; García-Fiñana M; Gummery A; Kneen R; Loring DW; Mawer G; Meador KJ; Shallcross R; Clayton-Smith J;
    Neurology; 2015 Jan; 84(4):382-90. PubMed ID: 25540307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
    Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J
    Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of valproate exposure in utero on behavior and the need for educational support in school-aged children.
    Viinikainen K; Eriksson K; Mönkkönen A; Aikiä M; Nieminen P; Heinonen S; Kälviäinen R
    Epilepsy Behav; 2006 Dec; 9(4):636-40. PubMed ID: 17049311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopment of children exposed in utero to lamotrigine, sodium valproate and carbamazepine.
    Cummings C; Stewart M; Stevenson M; Morrow J; Nelson J
    Arch Dis Child; 2011 Jul; 96(7):643-7. PubMed ID: 21415043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers.
    Campbell E; Kennedy F; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ; Craig J; Morrow J
    J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1029-34. PubMed ID: 24444855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate and pregnancy: think again.
    Kalayjian LA
    Neurology; 2015 Jan; 84(4):e25-6. PubMed ID: 25628438
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy.
    Wood AG; Nadebaum C; Anderson V; Reutens D; Barton S; O'Brien TJ; Vajda F
    Epilepsia; 2015 Jul; 56(7):1047-55. PubMed ID: 25963613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.
    Kini U; Adab N; Vinten J; Fryer A; Clayton-Smith J;
    Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F90-5. PubMed ID: 16239295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations.
    Lindhout D; Meinardi H; Meijer JW; Nau H
    Neurology; 1992 Apr; 42(4 Suppl 5):94-110. PubMed ID: 1574185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
    Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
    Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks of in utero exposure to valproate.
    Meador KJ; Loring DW
    JAMA; 2013 Apr; 309(16):1730-1. PubMed ID: 23613078
    [No Abstract]   [Full Text] [Related]  

  • 17. The longer term outcome of children born to mothers with epilepsy.
    Adab N; Kini U; Vinten J; Ayres J; Baker G; Clayton-Smith J; Coyle H; Fryer A; Gorry J; Gregg J; Mawer G; Nicolaides P; Pickering L; Tunnicliffe L; Chadwick DW
    J Neurol Neurosurg Psychiatry; 2004 Nov; 75(11):1575-83. PubMed ID: 15491979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiepileptic drug treatment in pregnancy: drug side effects in the neonate and neurological outcome.
    Koch S; Jäger-Roman E; Lösche G; Nau H; Rating D; Helge H
    Acta Paediatr; 1996 Jun; 85(6):739-46. PubMed ID: 8816215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal Valproate Syndrome - Still a Problem Today!
    Wiedemann K; Stüber T; Rehn M; Frieauff E
    Z Geburtshilfe Neonatol; 2017 Oct; 221(5):243-246. PubMed ID: 29073690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.